Kura Oncology, Inc. (KURA) Ownership

$7.86

north_east
$0.47 (6.36%)
Day's range
$7.26
Day's range
$7.9

Kura Oncology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2024 7.65 M $149.54 M   8.25% 8.80%
BLACKROCK FUNDING, INC. /DE 11/13/2024 7.16 M $139.82 M   100.00% 8.23%
ECOR1 CAPITAL, LLC 11/14/2024 5.81 M $113.47 M   0.00% 6.68%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2024 5.41 M $105.74 M   0.00% 6.22%
PARADIGM BIOCAPITAL ADVISORS LP 11/14/2024 4.33 M $84.63 M   -4.58% 4.98%
VANGUARD GROUP INC 11/13/2024 4.20 M $82.14 M   4.04% 4.83%
AVORO CAPITAL ADVISORS LLC 11/14/2024 3.54 M $69.20 M   0.00% 4.07%
BVF INC/IL 11/14/2024 3.37 M $65.88 M   -17.40% 3.88%
HOLOCENE ADVISORS, LP 11/14/2024 2.69 M $52.55 M   0.00% 3.09%
STATE STREET CORP 11/14/2024 2.67 M $52.15 M   -7.48% 3.07%
ARMISTICE CAPITAL, LLC 11/14/2024 2.66 M $51.94 M   13.11% 3.06%
DEEP TRACK CAPITAL, LP 11/14/2024 1.96 M $38.37 M   410.32% 2.26%
FORESITE CAPITAL MANAGEMENT IV, LLC 11/14/2024 1.85 M $36.15 M   0.00% 2.13%
COMMODORE CAPITAL LP 11/14/2024 1.80 M $35.17 M   12.97% 2.07%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.78 M $34.80 M   2.39% 2.05%
FRANKLIN RESOURCES INC 11/27/2024 1.59 M $28.69 M   1.48% 1.83%
TCG CROSSOVER MANAGEMENT, LLC 11/14/2024 1.42 M $27.82 M   0.00% 1.64%
SIREN, L.L.C. 11/13/2024 1.34 M $26.18 B   100.00% 1.54%
MORGAN STANLEY 11/14/2024 1.21 M $23.58 M   -9.17% 1.39%
CITADEL ADVISORS LLC 11/14/2024 1.19 M $23.23 M   17.36% 1.37%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 1.05 M $20.59 M   17.79% 1.21%
ASSENAGON ASSET MANAGEMENT S.A. 10/23/2024 1.05 M $20.56 M   -39.24% 1.21%
BOXER CAPITAL, LLC 11/14/2024 1.00 M $19.54 M   0.00% 1.15%
CANDRIAM S.C.A. 11/13/2024 906,482 $17.71 M   0.00% 1.04%
MILLENNIUM MANAGEMENT LLC 11/14/2024 845,194 $16.52 M   148.97% 0.97%
GOLDMAN SACHS GROUP INC 11/14/2024 709,484 $13.86 M   -14.71% 0.82%
PROSIGHT MANAGEMENT, LP 11/14/2024 705,109 $13.78 M   11.94% 0.81%
AFFINITY ASSET ADVISORS, LLC 11/13/2024 687,785 $13.44 M   5.81% 0.79%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 624,952 $12.21 M   2.31% 0.72%
SPHERA FUNDS MANAGEMENT LTD. 11/14/2024 610,087 $11.92 M   -0.12% 0.70%
WALLEYE CAPITAL LLC 11/14/2024 571,365 $11.16 M   661.00% 0.66%
ALETHEA CAPITAL MANAGEMENT, LLC 11/14/2024 553,542 $10.82 M   108.17% 0.64%
D. E. SHAW & CO., INC. 11/14/2024 423,208 $8.27 M   12.64% 0.49%
JPMORGAN CHASE & CO 12/26/2024 409,241 $8.00 M   0.76% 0.47%
DAFNA CAPITAL MANAGEMENT LLC 11/14/2024 408,368 $7.98 M   -3.57% 0.47%
BANK OF AMERICA CORP /DE/ 11/14/2024 350,415 $6.85 M   -12.95% 0.40%
SOFINNOVA INVESTMENTS, INC. 11/13/2024 296,884 $5.80 B   -64.02% 0.34%
ALLY BRIDGE GROUP (NY) LLC 11/14/2024 294,081 $5.75 M   -4.13% 0.34%
ALGERT GLOBAL LLC 11/12/2024 272,276 $5.32 M   4.41% 0.31%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 256,880 $5.02 M   -1.97% 0.30%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2024 252,770 $4.94 M   15.71% 0.29%
TWO SIGMA INVESTMENTS, LP 11/14/2024 208,239 $4.07 M   -23.52% 0.24%
BANK OF NEW YORK MELLON CORP 11/12/2024 205,678 $4.02 M   -19.62% 0.24%
ACUTA CAPITAL PARTNERS, LLC 11/14/2024 197,000 $3.85 M   20.86% 0.23%
EVERSEPT PARTNERS, LP 11/14/2024 192,398 $3.76 M   166.05% 0.22%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2024 189,103 $3.70 M   100.00% 0.22%
RHENMAN & PARTNERS ASSET MANAGEMENT AB 11/13/2024 166,526 $3.25 M   0.00% 0.19%
BARCLAYS PLC 11/19/2024 165,484 $3.23 M   104.50% 0.19%
WOODLINE PARTNERS LP 11/14/2024 143,207 $2.80 M   0.00% 0.16%
PROPEL BIO MANAGEMENT, LLC 11/13/2024 130,000 $2.54 M   0.00% 0.15%

Kura Oncology, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of KURA shares?

During the previous two years, 211 institutional investors and hedge funds held shares of Kura Oncology, Inc.. The most heavily invested institutionals were:

MASSMUTUAL TRUST CO FSB/ADV: 0

SUVRETTA CAPITAL MANAGEMENT, LLC: 7.65 M

BlackRock Funding, Inc. /DE: 7.16 M

EcoR1 Capital, LLC: 5.81 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 5.41 M

Paradigm Biocapital Advisors LP: 4.33 M

What percentage of Kura Oncology, Inc. stock is owned by institutional investors?

94.66% of Kura Oncology, Inc. stock is owned by institutional investors.

How much institutional buying is happening at KURA ?

Institutional investors have bought a total of 89.01 M shares in the last 24 months. This purchase volume represents approximately $699.65 M in transactions.